Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985685 · ClinicalTrials.gov registry record · Phase 2
The Effect of Thiamine vs. Placebo on VO2 in Critical Illness
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01985685 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT01985685, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effect of thiamine therapy on oxygen consumption (VO2) in critically-ill patients. We will evaluate this by measuring VO2 before and after thiamine or placebo administration in patients admitted to the ICU and requiring mechanical ventilation. A secondary aim is to evaluate the effect of thiamine vs. placebo on the metabolic profile of the patients.
Interventions
- DRUG Thiamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01985685
The ClinicalTrials.gov registry entry for NCT01985685 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thiamine is the first listed.
NCT01985685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01985685 about?
NCT01985685 is a clinical study titled "The Effect of Thiamine vs. Placebo on VO2 in Critical Illness". The objective of this study is to determine the effect of thiamine therapy on oxygen consumption (VO2) in critically-ill patients. We will evaluate this by measuring VO2 before and after thiamine or placebo administration in patients admitted to the ICU and requiring mechanical ventilation. A second...
What is the current status of trial NCT01985685?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2013-10. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01985685?
The interventions under investigation include: Thiamine (DRUG).
Who is sponsoring clinical trial NCT01985685?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.